Severe Pulmonary Infection in a 20-Month-Old Female

Yasmeen Mann1, Paul Zeller1, Kristen Carrillo-Kappus1

  • 1Central Michigan University College of Medicine, Mount Pleasant, MI 48858, USA.

Insights

Community-Acquired Pneumonia (CAP) in a pediatric patient presented with complex pleural effusion. Despite initial treatments, a rhinovirus/enterovirus infection was identified, highlighting diagnostic challenges in pediatric CAP cases.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Thoracic Surgery

Background:

  • Community-Acquired Pneumonia (CAP) is a frequent cause of pediatric hospitalization.
  • This case highlights the diagnostic and management complexities of complicated CAP with pleural effusions in a young child.

Observation:

  • A 20-month-old female presented with symptoms suggestive of CAP, including cough, fever, and dyspnea.
  • Initial imaging revealed left lower lobe pneumonia with a complex parapneumonic effusion.
  • Despite empiric antibiotics and initial surgical intervention, the patient developed persistent consolidation and air collection.

Findings:

  • A respiratory pathogen panel ultimately identified rhinovirus/enterovirus as the causative agent.
  • The patient required multiple interventions, including two video-assisted thoracoscopic surgical (VATS) decortications and chest tube placement.
  • Complications arose during initial VATS, necessitating transfer to the pediatric intensive care unit.

Implications:

  • This case underscores the importance of considering viral etiologies in severe pediatric CAP, even with initial bacterial suspicion.
  • Complex pleural effusions in children may require multidisciplinary management involving pulmonologists, infectious disease specialists, and thoracic surgeons.
  • Delayed diagnosis and management of pediatric CAP with empyema can lead to significant morbidity and long-term sequelae.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
437
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
717
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
931
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
674
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
682